Skip to main content
TipRanks
Go Ultimate75% OFF

Hikma Pharmaceuticals (HKMPY) Financial Statements

43 Followers

Hikma Pharmaceuticals Financial Overview

Hikma Pharmaceuticals's market cap is currently $4.47B. The company's EPS TTM is $3.60; its P/E ratio is 12.07; and it has a dividend yield of 3.90%. Hikma Pharmaceuticals has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 3.36B$ 3.13B$ 2.88B$ 2.52B$ 2.55B
Gross Profit$ 1.44B$ 1.42B$ 1.41B$ 1.24B$ 1.30B
Operating Income$ 569.33M$ 612.00M$ 367.00M$ 282.00M$ 582.00M
EBITDA$ 781.82M$ 727.00M$ 566.00M$ 691.00M$ 743.00M
Net Income$ 402.94M$ 359.00M$ 190.00M$ 188.00M$ 421.00M
Balance Sheet
Cash & Short-Term Investments$ 354.00M$ 213.00M$ 229.00M$ 292.00M$ 450.00M
Total Assets$ 5.67B$ 5.13B$ 4.68B$ 4.47B$ 4.37B
Total Debt$ 1.60B$ 1.31B$ 1.19B$ 1.28B$ 846.00M
Net Debt$ 1.28B$ 1.12B$ 986.00M$ 1.01B$ 420.00M
Total Liabilities$ 3.06B$ 2.81B$ 2.47B$ 2.32B$ 1.91B
Stockholders' Equity$ 2.59B$ 2.31B$ 2.20B$ 2.13B$ 2.45B
Cash Flow
Free Cash Flow$ 162.38M$ 329.00M$ 404.00M$ 305.00M$ 409.00M
Operating Cash Flow$ 359.84M$ 564.00M$ 608.00M$ 530.00M$ 638.00M
Investing Cash Flow$ -394.92M$ -381.00M$ -333.00M$ -607.00M$ -238.00M
Financing Cash Flow$ 58.14M$ -188.00M$ -337.00M$ -58.00M$ -287.00M

Currency in USD

Hikma Pharmaceuticals Earnings and Revenue History

-2B02B4B-60 %-30 %0 %30 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Hikma Pharmaceuticals Liabilities to Assets

02B4B6B42 %48 %54 %60 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Hikma Pharmaceuticals Cash Flow

-750M-500M-250M0250M500M750M201720182019202020212022202320242025OperatingInvestingFinancing

Hikma Pharmaceuticals Forecast EPS vs Actual EPS

11.31.51.822.32.5Q2 24Q4 24Q2 25Q4 25Q2 26Q4 26EPS EstimateBeatMiss